🔎 Trials Near Me

Hem › Autoimmuna sjukdomar › Michigan

Kliniska studier för Autoimmuna sjukdomar i Michigan

9 studier för Autoimmuna sjukdomar söker deltagare vid platser i Michigan.

Städer i Michigan

Officiell studietext (engelska)

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  • Clinical Research Inst of MI, Saint Clair Shores
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07621809

Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death

  • University of Michigan, Ann Arbor
RekryterarObservationsstudie
1 Month – 100 Years · Alla kön · Uppdaterad 24 sep. 2026 · NCT00246857

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • University of Michigan - Accepting Young Adult and Juvenile Patients, Ann Arbor
RekryterarFas 2/3
Ålder 6 till 75 · Alla kön · Uppdaterad 17 sep. 2026 · NCT06154252

Daratumumab in Primary Antiphospholipid Syndrome

  • University of Michigan, Ann Arbor
RekryterarFas 1/2
Ålder 18 till 65 · Alla kön · Uppdaterad 16 sep. 2026 · NCT05671757

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • University of Michigan, Ann Arbor
RekryterarFas 2/3
Ålder 18 till 75 · Alla kön · Uppdaterad 17 aug. 2026 · NCT06328777

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  • Site Number - 1026, Detroit
  • Site Number - 1005, East Lansing
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 30 juli 2026 · NCT07039916

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Michigan, Ann Arbor
  • Children's Hospital of Michigan, Detroit
  • Henry Ford Health System, Detroit
  • och 2 fler
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

  • Karmanos Cancer Institute, Detroit
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 25 feb. 2026 · NCT06626919

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.